| 2.21 Data as of 1:30pm ET |  -0.0201 / -0.90%Today’s Change | 2.05 Today|||52-Week Range 4.69 | +2.31% Year-to-Date |
| Previous close | 2.23 |
| Today’s open | 2.15 |
| Day’s range | 2.15 - 2.21 |
| Volume | 2,700 |
| Average volume (3 months) | 15,997 |
| Market cap | $28.5M |
| Dividend yield | -- |
| Earnings growth (last year) | +243.90% |
| Earnings growth (this year) | -208.74% |
| Earnings growth (next 5 years) | +18.00% |
| Revenue growth (last year) | -6.69% |
| P/E ratio | NM |
| Price/Sales | 0.48 |
| Price/Book | 0.93 |
| Today’s change | Today’s % change | |
|---|---|---|
| BPAXBioSante Pharmaceuti... | +0.09 | +7.83% |
| GOGCGlobal Green Inc | 0.00 | 0.00% |
| --Response Biomedical ... | 0.00 | 0.00% |
| ROSGRosetta Genomics Ltd | -0.02 | -0.50% |
| Next reporting date | August 12, 2013 |
| EPS forecast (this quarter) | -$0.27 |
| Annual revenue (last year) | $57.2M |
| Annual profit (last year) | $18.2M |
| Net profit margin | 31.96% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director James E. Levine, MBA |
Chief Operating Officer & Executive Vice President Janet S. Roemer, MBA |
Corporate headquarters San Diego, California |
.
